Champions Oncology, Inc. (NasdaqCM: CSBR)
Health Care · Life Sciences Tools & Services · US
$4.96
-2.07% today · -35.0% 1Y
Champions Oncology, Inc. (NasdaqCM: CSBR) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $68.91M and employs 214 people.
Over the last twelve months the share price has lost 35.0%, trading between 4.83 and 8.74.
Tweenvest scores Champions Oncology, Inc. across four factors: quality 54/100, value 76/100, growth 58/100. Its strongest factor is value.
CSBR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $68.91M
- Revenue (TTM)
- $59.42M
- P/E
- —
- EPS
- -0.08
- Dividend yield
- —
- Beta (5Y)
- 0.41
- 52-week high
- $8.74
- 52-week low
- $4.83
- Avg volume (3M)
- —
- Shares outstanding
- 13.89M
- Employees
- 214
- Next earnings
- —
About Champions Oncology, Inc.
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
- ISIN
- US15870P3073
- Founded
- 1985
- Listed since
- Feb 2, 2007
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF592.20 | +1.09% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.